Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
Category: Supply Chain
-
Here’s Why This Bouquet of Red Roses Costs $72 in NYC.
A dozen red roses is timeless. But its price tag is not. At Ditmars Flower Shop in Queens, where costs have soared in recent years, a bouquet is $72, up from $60 in 2019.
-
How Japan Is Trying to Rebuild Its Chip Industry
Taiwan’s semiconductor giant, TSMC, is quickly remaking a farm town in Japan into Asia’s next hub of chip manufacturing with enormous government support.
-
Yellen Faces Diplomatic Test in Urging China to Curb Green Energy Exports
The United States wants to persuade China to dial back its green energy industrial strategy as the Biden administration subsidizes its own supply chain.
-
How Boeing Favored Speed Over Quality for the 737 Max
Problems have plagued the manufacturer even after two fatal crashes, and many current and former employees blame its focus on making planes more quickly.
-
Baltimore Bridge Collapse Shows Fragility of Global Trade
The destruction of a Baltimore bridge has crippled a busy port, adding to the strains confronting the global supply chain.
-
Yellen to Warn China Against Flood of Cheap Green Energy Exports
The Treasury secretary, who plans to make her second trip to China soon, will argue that the country’s excess industrial production warps supply chains.
-
Chip Makers Searching for ‘China Plus 1’ Are Finding Malaysia
A flood of American and European companies are expanding there and around Southeast Asia, a sign of how geopolitics is reshaping tech manufacturing.